Genalyte is a health care diagnostics and analytics company that improves patient outcomes and lowers cost by offering real-time laboratory results for physicians and patients. Genalyte delivers rapid, actionable results to doctors through decentralized laboratory testing.
Our leadership team draws on diverse backgrounds spanning healthcare and technology.
Ashraf Hanna, MD PhD
Ashraf Hanna is the Chief Executive Officer of Genalyte. He has a has a Ph.D. in Physics from Harvard University, an M.D. from the University of Massachusetts, and was an undergraduate at the University of Chicago.
Previously he was the COO of Verily Life Sciences, an Alphabet company focused on leveraging data to improve healthcare outcomes, accessibility and cost. Prior to Verily, he was the CEO of ORIC Pharmaceuticals, a company developing treatments for cancer resistance, and before that, Ashraf spent nearly 11 years as a Vice President at Genentech leading the Commercial and Medical Affairs Finance functions, as well as Alliance Management and Portfolio Planning group, which is responsible for developing product plans, metrics and guiding R&D investments. Ashraf was also the CFO for the Genentech foundation, and previously at McKinsey and Company.
President , BaseHealth Analytics
Hossein is an experienced entrepreneur who has worked on developing various technologies and models for identification and characterization of numerous risk factors for common complex diseases for the past 20 years.
His latest startup BaseHealth which was founded by him in 2011, was a predictive
health analytics company that empowered leading health systems and Medicare Advantage plans to
maximize revenues, cost-savings and clinical outcomes through a proprietary machine learning and
artificial intelligence platform that was built on the most diverse and comprehensive set of data types in
the industry. Prior to that, Hossein was a founding member of ParAllele Bioscience, a startup company
that developed 2 main technologies for identification and scanning of genetic variations. ParAllele was
then acquired by Affymetrix, when Hossein took the lead of building and managing the Affymetrix’s
Genetic service lab.
Hossein earned his PhD in Medical Genetics from the Karolinska Institute in Sweden and completed his
post-Doctoral fellowship at Stanford Genome Technology Center. He has written over 20 peer-reviewed
publications in Journals and books and holds number of pending and issued patents.
RICK HOCKETT, MD
A clinical pathologist certified by the American Board of Pathology, Chief Medical Officer Rick Hockett is the mind behind Genalyte’s clinical strategy, development and operations.
He also oversees daily operations of our CLIA laboratory and 510(k) submission of our proprietary diagnostic instrumentation and assays for regulatory approval. Rick has spent three decades applying biomarkers to clinical medicine, distinguishing him as a leader in personalized medicine. Among many professional achievements, Rick was responsible for the first standalone genetic component for a New Drug Application to the U.S. Food and Drug Administration. Rick maintains active medical licenses in Indiana, California, New York and Colorado. He earned his bachelor’s degree in chemistry at the University of South Dakota and his doctorate of medicine from the University of Minnesota; he completed his residency in clinical pathology at Washington University, St. Louis. He is inspired by Genalyte’s mission to empower medical practitioners and patients through tech.
CTO, BaseHealth Analytics
Prakash has always been intrigued by the promise of data based medical care and in particular it’s role in moving to a more prevention-based paradigm.
In a long career in software development, he has helped build patient management and hospital management systems on multiple continents. Most recently he had executive leadership responsibilities at Hara Software, a KPCB backed startup that defined and lead the market in the energy management. Prior to that he spent more than a decade at Oracle, working with and leading teams that built, among other things, cutting edge performance management solutions for distributed Enterprise applications. Prakash holds a bachelor’s degree in Engineering and a master’s degree in business.
VP, Product Marketing
Michael leads Genalyte’s strategic direction by reading the market, identifying key market segments and designing innovative products and services to meet those needs.
Among his proudest career moments, O’Neil spearheaded the design and implementation of one of the first accountable care organizations in the country while serving as Senior Director of Product Innovation at Blue Shield of California. Improving quality of healthcare while cutting costs by almost $38 million in two years, the ACO model has been replicated by more than 32 medical groups and hospitals across the state. He earned his bachelor’s degree in political science from Dartmouth College and a master’s degree in education from Stanford University. With 20 years in the healthcare industry under his belt, O’Neil is inspired by Genalyte’s mission to improve patient-provider interactions with real-time data, and he’s proud to be part of bettering the lives of his friends, family and community.
SASI MUDUMBA, PHD
VP, Assay Development
Dr. Sasi Mudumba oversees the research, development, validation, regulatory submission and approval of the diagnostic assays at the heart of Genalyte’s revolutionary technology.
She has spent more than 20 years in research, development and commercialization in life sciences, drug discovery and medical devices. Mudumba has guided several In Vitro Diagnostics (IVD) products through approvals at federal agencies including the Food and Drug Administration and Health Canada, and was responsible for leading a multiplexed autoimmune IVD assay on microarray technology from development to regulatory approval. Her previous roles include Director of Assay Development at Regulatory Affairs at SQI Diagnostics and Senior Scientist at NoAb BioDiscoveries. Mudumba earned her bachelor’s degree in microbiology at Osmania University before obtaining her master’s degree in biochemistry from the Unviersity of Hyderabad; her PhD in biotechnology is from Jawaharlal Nehru Technological University. At Genalyte, she is excited to work with technology that speeds the diagnosis and treatment of autoimmune diseases.
Director, Human Resources
A 19-year veteran of her field, Madonna Moreno can be credited with shaping Genalyte’s innovative, dynamic culture by dictating company values and people strategy.
She is responsible Genalyte’s human resources functions including talent management, employee development, benefits, compensation, and business support. A leader in her field, Moreno is president of the San Diego Life Sciences HR Network, a nonprofit organization dedicated to developing innovation and strategic human resources practices in life sciences industries. Moreno is a Certified Professional in Human Resources and a Society for Human Resources Certified Professional. Moreno holds a bachelor’s degree in political science and a master’s in business administration, both from the University of San Diego. Having spent 11 years in biotechnology and life sciences companies — including Trovagene and the Salk Institute for Biological Studies — Moreno is passionate about working with innovative thinkers, and connecting talented people with meaningful opportunities to impact health and change lives.